You’re invited! Join LifeSite in celebrating 25 years of pro-life and pro-family reporting at our anniversary Gala August 17th in Naples, Florida. Tickets and sponsorships can be purchased by clicking here.
WASHINGTON, D.C. (LifeSiteNews) — D.C. schools have a new mandate requiring all students 12 and up to receive the experimental COVID-19 vaccine before returning to school this fall.
In a July 19 press release, the Office of the State Superintendent of Education directed that all students eligible for COVID-19 vaccines according to the Food and Drug Administration (FDA) must receive their vaccines for the 2022-2023 school year.
“We want to make sure that all of our students have everything they need for a healthy start to the school year,” said State Superintendent of Education Christina Grant. “This means making sure children see their primary medical provider for a well-child visit and receive all needed immunizations.”
The mandate extends to all schools, including private, parochial, and independent. Students must verify their vaccine status as part of enrollment and attendance requirements.
According to the mandate, all students 12 and up, unless exempted, must have received a series of COVID-19 shots or begun the process of vaccination before the start of the school year. The press release does not provide information on what kind of exemptions will be considered.
The mandate is part of the implementation of a COVID-19 vaccination law passed in D.C. last year. The law required all eligible teachers and students to receive the experimental vaccines.
On July 8, the FDA fully approved the Pfizer-BioNTech COVID-19 vaccine for children 12 to 15 years old, despite evidence showing the vaccine is more dangerous to children than the virus.
Similarly, the Centers for Disease Control Prevention (CDC) recently approved the experimental shots for children as young as six months old.
Meanwhile, a study from Johns Hopkins School of Medicine found a “mortality rate of zero among children without a pre-existing medical condition such as leukemia,” leading numerous experts to conclude that the benefits of injecting children against COVID-19 do not outweigh the risks.
Dr. Peter McCullough, MD, former professor of medicine at Texas A&M University Health Sciences Center, has called for an “unbreakable resistance” against children receiving the jab, citing numerous studies that show the “chance of myocarditis, and hospitalization with myocarditis, for one of these children who is going to be forced into vaccination … is greater than being hospitalized for COVID-19.”
Pediatric heart specialist Dr. Kirk Milhoan, who treated hundreds of COVID-19 patients, warned against vaccine mandates, which he asserts could have a lethal effect on children and lead to a surge of “sudden cardiac death” in young athletes.
Moreover, while the injections are touted for their “safety,” their admitted risk profiles have been expanded to include severe anaphylactic reactions, fatal thrombotic events, the inflammatory heart condition myocarditis, and neurologically disabling Guillain Barré Syndrome.
A November study from Hong Kong estimated that one in 2,680 boys between 12-17 years old will develop heart inflammation within two weeks of a second Pfizer jab. An article by Israeli researchers put the risk at one in 6,600 for young men ages 16-19, vaccinated with Pfizer vaccines.